Ochre Bio hits first partnership milestone by end of 2024? | Binary | | | 8 months ago | |
Ochre Bio's treatment in clinical trials by 2025? | Binary | | | 8 months ago | |
Clinical trial phase progression of Ochre Bio's treatment by 2026 | Categorical | | | 8 months ago | |
Will uninsured patients purchase Adalimumab-adbm at $550 by Oct 31, 2024? | Binary | | | 5 months ago | |
Will Pfizer announce Mikael Dolsten's successor by December 31, 2024? | Binary | | | 6 months ago | |
Who will be Pfizer's CEO at the end of 2024? | Categorical | | | 6 months ago | |
Scope expansion of Ochre Bio's treatments by end of 2025 | Categorical | | | 8 months ago | |
Total Boehringer Ingelheim payments to Ochre Bio by end of 2025 | Categorical | | | 8 months ago | |
Søren Tullin remains at his position through 2024? | Binary | | | 8 months ago | |
Will Pfizer's stock price increase by more than 10% by the end of 2024? | Binary | | | 6 months ago | |
Which company will Pfizer's new Chief Scientific Officer come from by December 31, 2024? | Categorical | | | 6 months ago | |
What percentage of uninsured patients will afford Adalimumab-adbm at $550 by Dec 31, 2024? | Categorical | | | 5 months ago | |
What will be the market share of Adalimumab-adbm among Humira biosimilars by Dec 31, 2024? | Categorical | | | 5 months ago | |
Will Adalimumab-adbm be available in retail pharmacies nationwide by Dec 31, 2024? | Binary | | | 5 months ago | |
Will Adalimumab-adbm be the lowest-priced Humira version by Dec 31, 2024? | Binary | | | 5 months ago | |
In how many states will Adalimumab-adbm be available at $550 by Nov 30, 2024? | Categorical | | | 5 months ago | |
Will Pfizer complete the integration of Seagen by the end of 2024? | Binary | | | 6 months ago | |
Who will be announced as Pfizer's new Chief Scientific Officer by December 31, 2024? | Categorical | | | 6 months ago | |
